We are live on
!
Find out more
NGM
North Growth Management Portfolio holdings
AUM
$780M
1-Year Est. Return
102.77%
This Fund
S&P 500
This Quarter
Est. Return
+15.94%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
–
AUM
$455M
AUM Growth
+$37M
(+8.9%)
Cap. Flow
-$6.67M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
34.53%
Holding
50
New
2
Increased
10
Reduced
11
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$9.12M |
| 2 |
Biogen
BIIB
|
+$8.93M |
| 3 |
Ciena
CIEN
|
+$3.63M |
| 4 |
D.R. Horton
DHI
|
+$3.62M |
| 5 |
Fortune Brands Innovations
FBIN
|
+$2.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$9.1M |
| 2 |
SolarEdge
SEDG
|
+$8.07M |
| 3 |
Pfizer
PFE
|
+$7.86M |
| 4 |
Cisco
CSCO
|
+$5.1M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$3.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.28% |
| 2 | Consumer Discretionary | 20.67% |
| 3 | Healthcare | 20.56% |
| 4 | Industrials | 11.38% |
| 5 | Communication Services | 4.11% |
Similar funds
PCM
SAM
QCM
AC
ABWM
HI
LTI
MAM
North Growth Management's Q3 2020 Portfolio in Review
As of Q3 2020, North Growth Management held 50 positions worth $455M, up 8.9% from $417M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
North Growth Management's Q3 2020 filing shows 2 new, 10 increased, 11 reduced and 3 closed positions. Its largest new stake was Lumentum: 110,000 shares worth $8.28M. The largest sale was Intel, an estimated $9.1M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 48% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- North Growth Management's largest Q3 2020 buy was Lumentum: 110,000 shares worth $8.28M.
- North Growth Management added most to Ciena in Q3 2020, an estimated $3.63M increase.
- North Growth Management's biggest Q3 2020 reduction was Intel, cutting an estimated $9.1M.
- North Growth Management fully exited Pfizer in Q3 2020, selling an estimated $7.86M.
- North Growth Management's ten largest holdings make up 35% of its $455M portfolio in Q3 2020.
- North Growth Management opened 2 new positions and closed 3 in Q3 2020.
- North Growth Management's portfolio value rose 8.9% quarter-over-quarter to $455M.
Based on North Growth Management's 13F filing for Q3 2020, filed 4 Nov 2020.